Please login to the form below

United BioSource Corporation

United BioSource Corporation is a global scientific and medical affairs organization that partners with life science companies to develop and commercialize their products. We help generate authoritative, real-world evidence of product effectiveness, safety and value to assist health care decisions and enhance patient care.

This is a FREE listing




Below are full profiles from other companies in this area

Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer.

View profile

Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Learn more about how we are Shortening the distance from lab to life® at syneoshealth.com.

View profile

Company Details

United BioSource Corporation

Telephone:+1 866 458 1096

Address:
7501 Wisconsin Avenue
Suite 705 , Bethesda
MD 20814
USA

Latest content from PMHub

Lucid Group Welcomes a New Cohort of Graduates into its Futures Academy
Lucid Group Communications Limited
Developing Innovative Digital Strategies to Engage Patients
Caitlin Wagner, Associate Marketing Director at Pharming, shares her expertise on innovative patient engagement strategies, including the roles of mobile apps and social media, the impact of the COVID-19 pandemic on how Pharma engages patients, and her predictions for the future. Impetus Digital
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer
Innovative Trials
6 critical success factors for flawless execution of a rapid first commercial launch
Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline.
Fishawack Health